{{Rsnum
|rsid=1370128
|Gene=IRAK3
|Chromosome=12
|position=66224858
|Orientation=plus
|GMAF=0.4991
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IRAK3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.9 | 47.8 | 20.4
| HCB | 22.6 | 46.7 | 30.7
| JPT | 19.6 | 51.8 | 28.6
| YRI | 4.1 | 32.7 | 63.3
| ASW | 10.5 | 50.9 | 38.6
| CHB | 22.6 | 46.7 | 30.7
| CHD | 12.8 | 56.0 | 31.2
| GIH | 44.6 | 45.5 | 9.9
| LWK | 2.8 | 39.4 | 57.8
| MEX | 55.2 | 39.7 | 5.2
| MKK | 9.0 | 49.7 | 41.3
| TSI | 34.3 | 47.1 | 18.6
| HapMapRevision=28
}}{{omim
|desc=ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5
|id=611064
|rsnum=1370128
}}

{{omim
|desc=INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3
|id=604459
|rsnum=1370128
}}

{{PMID Auto
|PMID=17503328
|Title=IRAK-M is involved in the pathogenesis of early-onset persistent asthma.
|OA=1
}}

{{PMID Auto
|PMID=22634523
|Title=Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}